- Home
- TLRY vs CBLL Comparison
TLRY vs CBLL Comparison
Compare TLRY & CBLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TLRY | CBLL |
|---|---|---|
| Founded | N/A | 2014 |
| Country | Canada | United States |
| Employees | N/A | 280 |
| Industry | Medicinal Chemicals and Botanical Products | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 688.9M | 750.1M |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | TLRY | CBLL |
|---|---|---|
| Price | $4.93 | $18.25 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 5 |
| Target Price | ★ $72.33 | $23.20 |
| AVG Volume (30 Days) | ★ 3.0M | 319.7K |
| Earning Date | 04-01-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $8.79 | $29.57 |
| Revenue Next Year | $19.98 | $28.44 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.36 | $10.85 |
| 52 Week High | $15.70 | $24.33 |
Technical Indicators
Market Signals| Indicator | TLRY | CBLL |
|---|---|---|
| Relative Strength Index (RSI) | 32.15 | 47.80 |
| Support Level | $1.12 | $17.17 |
| Resistance Level | $5.71 | $19.67 |
| Average True Range (ATR) | 0.25 | 0.78 |
| MACD | 0.00 | 0.05 |
| Stochastic Oscillator | 6.43 | 65.86 |
Price Performance
Historical ComparisonAbout TLRY Tilray Brands Inc.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mainly from alcohol.
About CBLL CeriBell Inc.
CeriBell Inc is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable and rapidly deployable hardware with sophisticated artificial intelligence (AI) powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions.